157 related articles for article (PubMed ID: 30459216)
1. A Vaccine Against Cervical Cancer: Context for the Global Public Health Practitioner.
Jennings MC; Loharikar A
Glob Health Sci Pract; 2018 Dec; 6(4):629-634. PubMed ID: 30459216
[TBL] [Abstract][Full Text] [Related]
2. Reaching teenagers with three-times jab is a first for most countries.
Adams P
Bull World Health Organ; 2012 Dec; 90(12):874-5. PubMed ID: 23284191
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus vaccination: expected impacts and unresolved issues.
Dempsey AF; Freed GL
J Pediatr; 2008 Mar; 152(3):305-9. PubMed ID: 18280831
[No Abstract] [Full Text] [Related]
4. [EUROGIN 2010: roadmap on cervical cancer prevention].
Monsonego J
Gynecol Obstet Fertil; 2011; 39(7-8):462-7. PubMed ID: 21764621
[No Abstract] [Full Text] [Related]
5. Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014.
Ladner J; Besson MH; Audureau E; Rodrigues M; Saba J
BMC Health Serv Res; 2016 Oct; 16(1):575. PubMed ID: 27737666
[TBL] [Abstract][Full Text] [Related]
6. [Health economic evaluation of human papillomavirus vaccines in the developing countries: systematic reviews].
Song X; Mao F; Zhou Z; Zhao Q; Fang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jan; 50(1):85-90. PubMed ID: 26792509
[TBL] [Abstract][Full Text] [Related]
7. Correlates of human papillomavirus vaccine coverage: a state-level analysis.
Moss JL; Reiter PL; Brewer NT
Sex Transm Dis; 2015 Feb; 42(2):71-5. PubMed ID: 25585064
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus, vaccines and women's health: questions and cautions.
Lippman A; Melnychuk R; Shimmin C; Boscoe M
CMAJ; 2007 Aug; 177(5):484-7. PubMed ID: 17671239
[No Abstract] [Full Text] [Related]
9. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
Goldie SJ; O'Shea M; Diaz M; Kim SY
Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
[TBL] [Abstract][Full Text] [Related]
10. Monitoring the coverage and impact of human papillomavirus vaccine - report of WHO meeting, November 2009.
Wkly Epidemiol Rec; 2010 Jun; 85(25):237-43. PubMed ID: 20583384
[No Abstract] [Full Text] [Related]
11. Human papillomavirus (HPV) and related cancers in the Global Alliance for Vaccines and Immunization (GAVI) countries. A WHO/ICO HPV Information Centre Report.
de Sanjosé S; Serrano B; Castellsagué X; Brotons M; Muñoz J; Bruni L; Bosch FX
Vaccine; 2012 Nov; 30 Suppl 4():D1-83, vi. PubMed ID: 23510764
[No Abstract] [Full Text] [Related]
12. Evaluating human papillomavirus vaccination programs.
Donovan B; Guy RJ
Sex Transm Dis; 2013 Apr; 40(4):290-1. PubMed ID: 23481536
[No Abstract] [Full Text] [Related]
13. Human papilloma virus vaccine for low and middle income countries: A step too soon?
Jindal HA; Kaur A; Murugan S
Hum Vaccin Immunother; 2017 Nov; 13(11):2723-2725. PubMed ID: 28846491
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
[TBL] [Abstract][Full Text] [Related]
15. An alert to Latin America: Current human papillomavirus vaccination trends highlight key barriers to successful implementation.
Nogueira-Rodrigues A; Bukowski A; Paulino E; St Louis J; Barrichello A; Sternberg C; Gifoni MAC; Luciani S; Goss PE
Cancer; 2017 Jun; 123(12):2193-2199. PubMed ID: 28440878
[No Abstract] [Full Text] [Related]
16. Time for change? An economic evaluation of integrated cervical screening and HPV immunization programs in Canada.
Tully SP; Anonychuk AM; Sanchez DM; Galvani AP; Bauch CT
Vaccine; 2012 Jan; 30(2):425-35. PubMed ID: 22075091
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccine risk and reality.
MacDonald N; Stanbrook MB; Hébert PC
CMAJ; 2008 Sep; 179(6):503, 505. PubMed ID: 18762616
[No Abstract] [Full Text] [Related]
18. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools].
Dillner J; Andrae B; Westermark B
Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260
[No Abstract] [Full Text] [Related]
19. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
[TBL] [Abstract][Full Text] [Related]
20. [The first HPV vaccine is now available].
Kjaer SK; Olesen F; Toftager-Larsen K; Sand C; Strauss GI; Hoffmann TU; Ottesen BS
Ugeskr Laeger; 2006 Oct; 168(44):3827-8. PubMed ID: 17118245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
